# Trade Mark Journal No.2026/025 19 June 2026

## WO0000001918919 (5)

Office of origin: United States of America

Date of International Registration:27 April 2026
Date of designation in the UK: 27 April 2026

International priority date claimed: 27 October 2025 (United States of America) (99464435)

Class 5
  Pharmaceutical preparations for the treatment of erythropoietic porphyria (EPP), X-linked protoporphyria (XLPP), genetic diseases and disorders, dermatological diseases and disorders, hematological diseases and disorders, liver diseases and disorders, and photosensitivity.

Disc Medicine, Inc.

Representative: Christina M. Licursi Wolf, Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210-2206, UNITED STATES OF AMERICA